Rhumbline Advisers Beam Therapeutics Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 127,105 shares of BEAM stock, worth $3.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
127,105
Previous 132,569 4.12%
Holding current value
$3.69 Million
Previous $3.11 Million 0.26%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$22.57 - $33.14 $123,322 - $181,076
-5,464 Reduced 4.12%
127,105 $3.11 Million
Q2 2024

Aug 01, 2024
BUY
$21.22 - $32.66 $500,049 - $769,632
23,565 Added 21.62%
132,569 $3.11 Million
Q1 2024

May 09, 2024
BUY
$23.46 - $45.07 $112,420 - $215,975
4,792 Added 4.6%
109,004 $3.6 Million
Q4 2023

Feb 08, 2024
SELL
$17.69 - $30.76 $22,713 - $39,495
-1,284 Reduced 1.22%
104,212 $2.84 Million
Q3 2023

Nov 09, 2023
BUY
$23.01 - $32.46 $239,580 - $337,973
10,412 Added 10.95%
105,496 $2.54 Million
Q2 2023

Aug 08, 2023
BUY
$29.32 - $35.99 $209,227 - $256,824
7,136 Added 8.11%
95,084 $3.04 Million
Q1 2023

May 11, 2023
BUY
$30.15 - $48.79 $42,451 - $68,696
1,408 Added 1.63%
87,948 $2.69 Million
Q4 2022

Feb 14, 2023
BUY
$36.73 - $51.6 $58,143 - $81,682
1,583 Added 1.86%
86,540 $3.39 Million
Q3 2022

Nov 10, 2022
BUY
$39.79 - $70.31 $348,679 - $616,126
8,763 Added 11.5%
84,957 $4.05 Million
Q2 2022

Aug 11, 2022
BUY
$29.86 - $62.36 $656,681 - $1.37 Million
21,992 Added 40.57%
76,194 $2.95 Million
Q1 2022

May 12, 2022
BUY
$53.73 - $82.16 $128,360 - $196,280
2,389 Added 4.61%
54,202 $3.11 Million
Q4 2021

Feb 10, 2022
SELL
$68.02 - $99.06 $8,706 - $12,679
-128 Reduced 0.25%
51,813 $4.13 Million
Q3 2021

Nov 12, 2021
BUY
$84.37 - $133.6 $270,827 - $428,856
3,210 Added 6.59%
51,941 $4.52 Million
Q2 2021

Aug 05, 2021
BUY
$64.12 - $128.71 $322,523 - $647,411
5,030 Added 11.51%
48,731 $6.27 Million
Q1 2021

May 06, 2021
SELL
$71.28 - $120.75 $180,766 - $306,222
-2,536 Reduced 5.48%
43,701 $3.5 Million
Q4 2020

Feb 10, 2021
BUY
$22.24 - $95.63 $204,696 - $880,178
9,204 Added 24.85%
46,237 $3.78 Million
Q3 2020

Nov 12, 2020
BUY
$19.0 - $30.57 $425,334 - $684,340
22,386 Added 152.84%
37,033 $912,000
Q2 2020

Aug 13, 2020
BUY
$15.26 - $28.66 $45,078 - $84,661
2,954 Added 25.26%
14,647 $410,000
Q1 2020

May 06, 2020
BUY
$13.31 - $29.2 $155,633 - $341,435
11,693 New
11,693 $210,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $2.04B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email